Home LiteratureArticle Details
PMID: 12486261 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.

Journal of neurology, neurosurgery, and psychiatry ·Vol. 74 ·No. 1 ·2003-01-00 ·Pages 25-8

Sumelahti ML, Tienari PJ, Hakama M, Wikström J

Abstract

To compare the secular trends and geographical differences in the incidence of relapsing-remitting (RRMS) and primary progressive multiple sclerosis (PPMS) in Finland, and to draw inferences about aetiological differences between the two forms of the disease. New multiple sclerosis cases in southern Uusimaa and the western districts Vaasa and Seinäjoki of Finland in 1979-1993 were verified from hospital records and classified into RRMS and PPMS. Patients met the Poser criteria for definite multiple sclerosis or otherwise satisfied the criteria for PPMS. Disease course was categorised by the same neurologist. Crude and age adjusted incidence in 1979-1993 was estimated. During 1979-1993 the age adjusted incidence was 5.1 per 100 000 person-years in Uusimaa, 5.2 in Vaasa, and 11.6 in Seinäjoki. The rates in Uusimaa remained stable, while a decrease occurred in Vaasa and an increase in Seinäjoki. Between 1979-86 and 1987-93 the incidence of PPMS increased in Seinäjoki from 2.6 to 3.7 per 10(5) and decreased in Vaasa from 1.9 to 0.2 per 10(5); the trends were similar for RRMS. There are significant differences in secular trends for multiple sclerosis incidence in Finland by geographical area, but these are similar for PPMS and RRMS. The recent changes point to locally acting environmental factors. The parallel incidence trends for RRMS and PPMS suggest similar environmental triggers for the two clinical presentations of multiple sclerosis.

MeSH Terms
Adolescent Adult Aged Child Demography Disease Progression Female Finland/epidemiology Humans Incidence Male Middle Aged Multiple Sclerosis/epidemiology Multiple Sclerosis, Chronic Progressive/epidemiology Multiple Sclerosis, Relapsing-Remitting/epidemiology
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Sumelahti M-L
School of Public Health, University of Tampere, PO Box 607, FIN-33101 Tampere, Finland. [email protected]
Tienari P J
Hakama M
Wikström J
References (33)
33 references, click to expand
  1. Clinical and laboratory features of primary progressive and secondary progressive MS.
    Neurology. 1999 Sep 11;53(4):765-71 PMID: 10489038
  2. Studies on the clustering of multiple sclerosis in Finland II: microepidemiology in one high-risk county with special reference to familial cases.
    Acta Neurol Scand. 1975 Mar;51(3):173-83 PMID: 1146497
  3. Geography in multiple sclerosis.
    J Neurol. 1977 Apr 28;215(1):1-26 PMID: 67196
  4. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.
    Brain. 1980 Jun;103(2):281-300 PMID: 7397479
  5. Genetic markers in Finland.
    Haematologia (Budap). 1980;13(1-4):65-74 PMID: 6941915
  6. New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
    Ann Neurol. 1983 Mar;13(3):227-31 PMID: 6847134
  7. The epidemiology of multiple sclerosis in Finland: increase of prevalence and stability of foci in high-risk areas.
    Acta Neurol Scand. 1983 May;67(5):255-62 PMID: 6880604
  8. Multiple sclerosis after age 50.
    Neurology. 1983 Dec;33(12):1537-44 PMID: 6606140
  9. Western Norway, a high-risk area for multiple sclerosis: a prevalence/incidence study in the county of Hordaland.
    Neurology. 1984 Sep;34(9):1202-7 PMID: 6540405
  10. Histocompatibility antigens in familial multiple sclerosis in a high-risk area of the disease.
    J Neurol Sci. 1984 Aug;65(2):147-55 PMID: 6592288
  11. Multiple sclerosis--more than one disease?
    Acta Neurol Scand. 1985 Aug;72(2):145-50 PMID: 4050323
  12. Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study.
    Acta Neurol Scand. 1988 Jul;78(1):10-5 PMID: 3176876
  13. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.
    Brain. 1989 Feb;112 ( Pt 1):133-46 PMID: 2917275
  14. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities.
    Proc Natl Acad Sci U S A. 1989 Sep;86(18):7113-7 PMID: 2571150
  15. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.
    BMJ. 1990 Mar 10;300(6725):631-4 PMID: 2138923
  16. Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis.
    Brain. 1990 Dec;113 ( Pt 6):1597-628 PMID: 2276037
  17. Incidence of multiple sclerosis in Hordaland, western Norway: a fluctuating pattern.
    Neuroepidemiology. 1991;10(2):53-61 PMID: 2062418
  18. Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene.
    Lancet. 1992 Oct 24;340(8826):987-91 PMID: 1383661
  19. Prevalence, incidence, and characteristics of multiple sclerosis in Westlock County, Alberta, Canada.
    Neurology. 1993 Sep;43(9):1760-3 PMID: 8414027
  20. Disease gene mapping in isolated human populations: the example of Finland.
    J Med Genet. 1993 Oct;30(10):857-65 PMID: 8230163
  21. A comparison of the pathology of primary and secondary progressive multiple sclerosis.
    Brain. 1994 Aug;117 ( Pt 4):759-65 PMID: 7922463
  22. Surveying multiple sclerosis in the United Kingdom.
    J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):2-6 PMID: 7823061
  23. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis.
    Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7440-4 PMID: 7638210
  24. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
    Neurology. 1996 Apr;46(4):907-11 PMID: 8780061
  25. Unique HLA antigen frequencies in the Finnish population.
    Tissue Antigens. 1996 Dec;48(6):703-7 PMID: 9008314
  26. Primary progressive multiple sclerosis.
    Brain. 1997 Jun;120 ( Pt 6):1085-96 PMID: 9217691
  27. Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK.
    J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):451-4 PMID: 9576534
  28. Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979-1993.
    Neuroepidemiology. 2000 Mar-Apr;19(2):67-75 PMID: 10686531
  29. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.
    Brain. 1999 Oct;122 ( Pt 10):1941-50 PMID: 10506095
  30. HLA-DRB1 and disease outcome in multiple sclerosis.
    J Neurol. 2001 Apr;248(4):304-10 PMID: 11374095
  31. Distribution of multiple sclerosis in Finland, with special reference to some geological factors.
    Acta Neurol Scand. 1966;42(4):385-99 PMID: 5919814
  32. Studies on the clustering of multiple sclerosis in Finland I: Comparison between the domiciles and places of birth in selected subpopulations.
    Acta Neurol Scand. 1975 Feb;51(2):85-98 PMID: 1114880
  33. HLA-DR15 is associated with lower age at onset in multiple sclerosis.
    Ann Neurol. 2000 Aug;48(2):211-9 PMID: 10939572
Article Info
Journal
Journal of neurology, neurosurgery, and psychiatry
Abbr.
J Neurol Neurosurg Psychiatry
ISSN
0022-3050
Published
2003-01-00
Pages
25-8
Language
English
Region
England
NLM ID
2985191R
PMCID
PMC1738192
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]